InvestorsHub Logo
Followers 5
Posts 2466
Boards Moderated 0
Alias Born 08/16/2016

Re: None

Friday, 03/04/2022 10:12:22 PM

Friday, March 04, 2022 10:12:22 PM

Post# of 3196
It's been said the Nuplazid sales have peaked...
It would be an improvement if Nuplazid was submitted for sales overseas.
It would be an improvement if Nuplazid was approved in the USA for schizophrenia and of course DRP.
I realize Nuplazid can be prescribed off-label.
I predict the FDA will reject the 2nd sNDA for Nuplazid DRP.
I think ACAD has tried to grow too quickly with a giant sales force.
I think ACAD has tried to grow to quickly with their expensive, multi-million dollar, new research center in Sweden.
Acadia has an "open-shirt" style of management.
Get ready for the Acadia stock price to drop more and more.
Get ready for the dem government to fully take over healthcare and screw over profits.
Get ready for the big drop and the great reset, so we are all poor poppers to our elite and rich government leaders...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACAD News